ライフサイエンスコーパス: Japanese population

1 ) and autosomal recessive CORD (9.9%) in the Japanese population.

2 a and facilitates PCa risk stratification in Japanese population.

3 cohort pattern of H. pylori infection in the Japanese population.

4 2 polymorphisms were associated with BD in a Japanese population.

5 dataset that covers approximately 2% of the Japanese population.

6 g ethnicities, which was most evident in the Japanese population.

7 ucted a meta-analysis of GWAS for T2D in the Japanese population.

8 a poor response to latanoprost in a healthy Japanese population.

9 343A variant was exclusively observed in the Japanese population.

10 neates the disease spectrum of CRX-RD in the Japanese population.

11 ously reported to be associated with RA in a Japanese population.

12 the asporin gene was recently reported in a Japanese population.

13 eptibility to rheumatoid arthritis (RA) in a Japanese population.

14 esity and periodontal disease was found in a Japanese population.

15 identical to ancestral haplotype 7.2 in the Japanese population.

16 e, underlying infection in a community-based Japanese population.

17 were originally thought to be unique to the Japanese population.

18 loss of activity, which occurs in 4% of the Japanese population.

19 fine-scale mapping of a rare disease in the Japanese population.

20 c cancer patients and 32,592 controls in the Japanese population.

21 ustralian populations, was not found in this Japanese population.

22 heterozygous trait is present in 27% in the Japanese population.

23 e presence of the risk allele of IRF8 in the Japanese population.

24 insights into genetic characteristics of the Japanese population.

25 -report questionnaire for periodontitis in a Japanese population.

26 ed on a positively selected haplotype in the Japanese population.

27 d AD-COD/CORD has never been reported in the Japanese population.

28 n, found with small frequency in Chinese and Japanese populations.

29 (kidney stones) in the Northern European and Japanese populations.

30 DQA1-DQB1 data from Caucasian, African, and Japanese populations.

31 uated in cohorts from the CEPH, African, and Japanese populations.

32 wer plasticity in basal diameter compared to Japanese populations.

33 bility of height between the UK, Chinese and Japanese populations.

34 rge-scale meta-analysis of two GWAS from the Japanese population (1,583 cases and 3,386 controls) and

35 mapping results of hematopoietic traits in a Japanese population, 1549 putative causal splice QTLs (s

36 g analysis of rheumatoid arthritis (RA) in a Japanese population (6,244 RA cases and 23,731 controls)

37 y associated with atrial fibrillation in the Japanese population after comparing our data to those fr

38 areas using microsatellite markers, with one Japanese population also examined.

39 f iPSCs that covers approximately 40% of the Japanese population and describe quality and safety cons

40 This SNP is common (>18%) in the Japanese population and indicates that the increased sen

41 ped microsimulation model was adapted to the Japanese population and updated with Japan-specific heal

42 nome-wide association studies in British and Japanese populations and a trans-ethnic meta-analysis th

43 activation, confers susceptibility to KD in Japanese populations and increases the risk of developin

44 1; SLC22A4) gene was associated with RA in a Japanese population, and a haplotype of a different SNP

45 ommon autosomal recessive diseases among the Japanese population, and yet few patients outside of Jap

46 (27% after multiple-testing correction) in a Japanese population-based cohort (N = 2,862; 68.3 +/- 5.

47 We used the Japanese population-based repository database of OHCA an

48 inese and the Japanese populations, with the Japanese population being the less diverse.

49 nt is present at a frequency of 23.7% in the Japanese population but is absent in Caucasoids.

50 This preference applied across UK and Japanese populations but was stronger for within-populat

51 ormed a genome-wide association study in the Japanese population comprising 9,826 cases among 150,272

52 However, plants from both introduced and Japanese populations expressed higher clonality and plas

53 se populations, North American, European and Japanese populations expressed lower trait values and pl

54 was effective for imputing genotypes of the Japanese population genome wide.

55 In the Japanese population, half of the cases analyzed appear t

56 Candidate gene studies in the Japanese population have implicated signal transducer an

57 Prospective cohort studies in Japanese populations have shown an inverse association b

58 eptibility haplotype associated with RA in a Japanese population is not associated with RA in a UK po

59 In this long-lived Japanese population, mosaic chromosomal alterations were

60 A random Japanese population (n = 129) and a collection of multie

61 A-UMAP) to biobank-derived genomic data of a Japanese population (n = 169,719).

62 elation to atopic and non-atopic asthma in a Japanese population (n = 400).

63 A recent study in a Japanese population of Kawasaki disease patients at high

64 i are associated with kidney function in the Japanese population, our genome-wide association study u

65 This large-scale GWAS in a Japanese population provides insights into the etiology

66 y Japanese individuals and construction of a Japanese population reference panel (1KJPN).

67 Further characterization of a Japanese population shows that at least part of the incr

68 In contrast to the previous reports in a Japanese population, SSc patients of EA did not show an

69 ugh 52.6% (51 of 97) of the samples from the Japanese population tested had very high antibody titers

70 EWEL revealed genetic characteristics of the Japanese population that were not discernible using micr

71 As in the Japanese population, the SNPs in the UK population defin

72 In contrast to studies in Japanese populations, this study did not show a statisti

73 the applicability of the tripartite model to Japanese populations throughout the archipelago, with an

74 , for which the allele frequency (AF) in the Japanese population was 2.2% and 3.0%, respectively.

75 The status of IPF in the Japanese population was clarified for the first time thr

76 Meta-analysis with Korean and Japanese population was done.

77 ts associated with smoking behaviours in the Japanese population, we conducted a genome-wide associat

78 i associated with atrial fibrillation in the Japanese population, we performed a genome-wide associat

79 e genetic basis of heart failure (HF) in the Japanese population, we performed genome-wide associatio

80 or type 1 diabetes (T1D) for the Swedish and Japanese populations, we determined that T1D risk-associ

81 typing CNVs in the CEPH, Yoruba, and Chinese-Japanese populations, we estimated that at least 11% of

82 frican American, European American (EA), and Japanese populations, we have identified a novel polymor

83 ncer cases and 12 558 non-cancer controls of Japanese populations, we identified a susceptibility loc

84 At baseline, 13.6% of the Japanese population were underweight and 5.0% in the Wes

85 hearing loss families from both American and Japanese populations were screened for mutations.

86 tylhydrolase activity is absent in 4% of the Japanese population, which suggests that it could be a c

87 lear distinction between the Chinese and the Japanese populations, with the Japanese population being

88 e I (HTLV-I) infection was investigated in a Japanese population within an area in which HTLV-I infec